Insider · CIK 0001058190

WESSON BRUCE F

Reports to the SEC for 6 companies · STAMFORD, CT

sec.gov

Transactions

Companies

Filings

CIK

0001058190

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-01-02	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	+37.5K sh	—	—	829,548
2024-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)M Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	−37.5K sh	—	—	12,500
2024-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)D Disposition to Issuer	Director, Director Emeritus	DDisposition to Issuer	−12.5K sh	—	—	0
2023-01-03	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	+66.7K sh	—	—	792,048
2023-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)M Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	−66.7K sh	—	—	0
2023-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)A Award	Director, Director Emeritus	AAward	−50K sh	—	—	50,000
2022-01-03	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	+66.7K sh	—	—	725,382
2022-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)M Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	−66.7K sh	—	—	0
2022-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)A Award	Director, Director Emeritus	AAward	−66.7K sh	—	—	66,666
2021-05-25	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)A Award	Director, Director Emeritus	AAward	+66.7K sh	—	—	66,666
2021-01-04	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	+54.8K sh	—	—	658,716
2021-01-04	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2017 Plan)M Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	−54.8K sh	—	—	0
2020-01-02	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	+83.3K sh	—	—	603,926
2020-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2017 Plan)M Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	−83.3K sh	—	—	0
2020-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2017 Plan)A Award	Director, Director Emeritus	AAward	+54.8K sh	—	—	54,790
2019-01-02	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	+66.7K sh	—	—	520,593
2019-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2017 Plan)M Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	−66.7K sh	—	—	0
2019-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2017 Plan)A Award	Director, Director Emeritus	AAward	+83.3K sh	—	—	83,333
2018-01-02	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	+59.5K sh	—	—	453,927
2018-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	−59.5K sh	—	—	0
2018-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsA Award	Director, Director Emeritus	AAward	+66.7K sh	—	—	66,666
2017-12-14	ACURA PHARMACEUTICALS, INCP Purchase	Director, Director Emeritus	PPurchase	+336K sh	$0.10	+$33.6K	394,404
2017-01-03	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	+22K sh	—	—	58,670
2017-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	−22K sh	—	—	0
2017-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsA Award	Director, Director Emeritus	AAward	+59.5K sh	—	—	59,523
2016-05-31	DERMA SCIENCES, INC.Stock Option (right to buy)A Award	Former Director	AAward	+20K sh	—	—	0
2016-01-27	MEDASSETS INCD Disposition to Issuer	Director	DDisposition to Issuer	−101K sh	—	—	0
2016-01-27	MEDASSETS INCStock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,966 sh	—	—	0
2016-01-27	MEDASSETS INCStock-Settled Stock Appreciation RightsD Disposition to Issuer	Director	DDisposition to Issuer	−16.7K sh	—	—	0
2016-01-27	MEDASSETS INCStock-Settled Stock Appreciation RightsD Disposition to Issuer	Director	DDisposition to Issuer	−18.2K sh	—	—	0
2016-01-04	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	+10.3K sh	—	—	36,644
2016-01-04	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	−10.3K sh	—	—	0
2016-01-04	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsA Award	Director, Director Emeritus	AAward	+22K sh	—	—	22,026
2015-08-13	DERMA SCIENCES, INC.P Purchase	Former Director	PPurchase	+10K sh	$6.58	+$65.8K	94,963
2015-05-28	DERMA SCIENCES, INC.A Award	Former Director	AAward	+10K sh	—	—	84,963
2015-03-06	MEDASSETS INCA Award	Director	AAward	+9,206 sh	—	—	9,206
2015-01-02	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	+36.8K sh	—	—	131,678
2015-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsM Exercise/Conversion	Director, Director Emeritus	MExercise/Conversion	−36.8K sh	—	—	0
2015-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsA Award	Director, Director Emeritus	AAward	+51.5K sh	—	—	51,546
2014-03-07	MEDASSETS INCG Gift	Director	GGift	−11.3K sh	—	—	84,021
2014-02-27	MEDASSETS INCA Award	Director	AAward	+7,411 sh	—	—	7,411
2013-11-21	MEDASSETS INCS Sale	Director	SSale	−1 sh	$20.82	−$20.82	90,131
2013-11-20	MEDASSETS INCM Exercise/Conversion	Director	MExercise/Conversion	+18.9K sh	$9.29	+$175K	109,021
2013-11-20	MEDASSETS INCM Exercise/Conversion	Director	MExercise/Conversion	+12.8K sh	$9.68	+$124K	121,800
2013-11-20	MEDASSETS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,223 sh	$2.86	+$6,357.78	124,023
2013-11-20	MEDASSETS INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$2.86	+$57.2K	144,024
2013-11-20	MEDASSETS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,370 sh	—	—	150,394
2013-11-20	MEDASSETS INCS Sale	Director	SSale	−53.9K sh	$20.54	−$1.11M	96,501
2013-11-20	MEDASSETS INCS Sale	Director	SSale	−6,369 sh	$20.58	−$131K	90,132
2013-11-20	MEDASSETS INCStock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0

Recent filings

Accepted (ET)
Jan 24
WESSON BRUCE F0001104659-24-000283
SEC(opens sec.gov)
Jan 54
WESSON BRUCE F0001104659-23-001404
SEC(opens sec.gov)
Jan 114
WESSON BRUCE F0001104659-22-003166
SEC(opens sec.gov)
May 284
WESSON BRUCE F0001104659-21-074160
SEC(opens sec.gov)
Jan 64
WESSON BRUCE F0001104659-21-001507
SEC(opens sec.gov)
Jan 64
WESSON BRUCE F0001104659-20-001551
SEC(opens sec.gov)
Jan 84
WESSON BRUCE F0001144204-19-001100
SEC(opens sec.gov)
Jan 34
WESSON BRUCE F0001209191-18-000785
SEC(opens sec.gov)

Companies

Address

C/O GALEN MANAGEMENT, L.L.C. 680 WASHINGTON BOULEVARD

STAMFORD, CT, 06901